Advertisement
Advertisement
June 13, 2024
Emergency Scientific Announces First Use of the Landmark Balloon Catheter for REBOA
June 13, 2024—Emergency Scientific announced the first patient use of its Landmark catheter for resuscitative endovascular occlusion of the aorta (REBOA).
Emergency Scientific, a Utah-based medical device company specializing in solutions for emergency medicine, advised that the Landmark REBOA catheter recently received FDA 510(k) clearance. It is indicated for temporary occlusion of large vessels, including patients requiring emergency control of hemorrhage.
The first procedure with the device was performed by Scott T. Youngquist, MD, an emergency medicine physician at University of Utah in Salt Lake City, Utah.
“Landmark was easy to use and easy to deliver with a smooth insertion,” commented Dr. Youngquist in the company’s press release. “REBOA can be an important tool to aid in patient resuscitation.”
According to the company, the REBOA procedure was developed by the military to treat hemorrhage from noncompressible fractures of the pelvis and penetrating trauma of the abdomen and has since been adopted by civilian providers. REBOA is also used for abdominal aortic aneurysm rupture, cardiac arrest, postpartum hemorrhage, and gastrointestinal bleed.
Advertisement
Advertisement
